小儿健脾补肺膏方对儿童反复呼吸道感染的疗效及其免疫机制

莫珊; 蔡靖宜; 黎家楼; 黄卓红; 吴声振

doi:10.3981/j.issn.1000-7857.2022.23.008

PDF(556 KB)

科技导报 ›› 2022, Vol. 40 ›› Issue (23) : 66-71. DOI: 10.3981/j.issn.1000-7857.2022.23.008

专题：中医药传承与临床实践

小儿健脾补肺膏方对儿童反复呼吸道感染的疗效及其免疫机制

作者信息 -

1. 佛山复星禅诚医院中医科, 佛山 528000;
2. 佛山复星禅诚医院中药科, 佛山 528000

作者简介:

莫珊，主任中医师，研究方向为儿科疾病的中医药干预，电子信箱： 1549505114@qq.com

Therapeutic effect of Xiaoer Jianpi Bufei ointment on recurrent respiratory tract infection in children and its immune mechanism

Author information -

1. Department of Traditional Chinese Medicine, Foshan Fosun Chancheng Hospital, Foshan 528000, China;
2. Department of Pharmacy of Traditional Chinese Medicine, Foshan Fosun Chancheng Hospital, Foshan 528000, China

摘要

为探讨小儿健脾补肺膏方治疗儿童反复呼吸道感染（RRTI）的疗效及对患儿免疫功能的影响，将2019年1月至2020年12月佛山复星禅诚医院收治的RRTI患儿随机分为中西医组（小儿健脾补肺膏方+免疫活性肽）与对照组（免疫活性肽），指标包括外周血CD3+、CD4+和CD8+流式细胞检测、最大呼气流量（PEF）及RRTI中医证候评分，随访至治疗后1年。结果显示，治疗后中西医组的CD3+和CD4+水平、PEF、RRTI中医证候评分均显著高于对照组，中西医组治疗期间的不良反应（2.22%）低于对照组（13.33%），而临床有效率（97.77%）高于对照组（84.44%）；说明小儿健脾补肺膏方+免疫活性肽治疗儿童RRTI的中西医结合方案可进一步提高患儿的免疫水平，具有改善呼气功能、临床症状的优势，有利于提高安全性及临床疗效。

Abstract

In order to identify the efficacy of Xiaoer Jianpi Bufei ointment on the treatment of recurrent respiratory tract infection (RRTI) in children and its potential immunology mechanism, children with RRTI admitted to Foshan Fuxing Chancheng hospital from Jan 2019 to Dec 2020 were randomly divided into the combination group of traditional Chinese medicine (TCM) and western medicine (Xiaoer Jianpi Bufei ointment + immunoactive peptide) and control group (immunoactive peptide). Indicators included: the peripheral blood CD3+, CD4+ and CD8+ detected by flow cytometry, maximum expiratory flow (PEF), and TCM syndrome score for RRTI. Subjects were followed up to 1 year after the treatment. The results showed that after the treatment, the levels of CD3+ and CD4+ , PEF, RRTI and TCM syndrome scores of the combination group were significantly higher than those of the control group. During the treatment, the adverse reactions (2.22%) of the combination group were lower than those of the control group (13.33%), and finally the efficacy of the combination group (97.77%) was higher than that of the control group (84.44%). It suggests that the integrated Chinese and western medicines of Xiaoer Jianpi Bufei ointment combined with immunoactive peptide for treatment of children's RRTI can further improve the immune level and expiratory function, and relieve the clinical symptoms, which may improve the clinical safety and efficacy.

导出引用

莫珊, 蔡靖宜, 黎家楼, 黄卓红, 吴声振. 小儿健脾补肺膏方对儿童反复呼吸道感染的疗效及其免疫机制[J]. 科技导报, 2022, 40(23): 66-71 https://doi.org/10.3981/j.issn.1000-7857.2022.23.008

MO Shan, CAI Jingyi, LI Jialou, HUANG Zhuohong, WU Shengzhen. Therapeutic effect of Xiaoer Jianpi Bufei ointment on recurrent respiratory tract infection in children and its immune mechanism[J]. Science & Technology Review, 2022, 40(23): 66-71 https://doi.org/10.3981/j.issn.1000-7857.2022.23.008

参考文献

[1] Zhou B, Niu W, Liu F, et al. Risk factors for recurrent respiratory tract infection in preschool-aged children[J]. Pediatric Research, 2021, 90(1):223-231.
[2] Jurkiewicz D, Zielnik-Jurkiewicz B. Bacterial lysates in the prevention of respiratory tract infections[J]. The Polish Otolaryngology, 2018, 72(5):1-8.
[3] Ferrara P, Ianniello F, Bianchi V, et al. Beneficial therapeutic effects of vitamin C on recurrent respiratory tract infections in children:Preliminary data[J]. Minerva Pediatrica, 2021, 73(1):22-27.
[4] Esposito S, Soto-Martinez M E, Feleszko W, et al. Nonspecific immunomodulators for recurrent respiratory tract infections, wheezing and asthma in children:A systematic review of mechanistic and clinical evidence[J]. Current Opinion in Allergy&Clinical Immunology, 2018, 18(3):198-209.
[5] Wu Y, Dong X, Wu R, et al. Efficacy and safety of spleen aminopeptide oral lyophilized powder in ameliorating liver injury in infants and children with human cytomegalovirus infection:A single-center study in China[J]. Translation Pediatrics, 2021, 10(1):136-145.
[6] Shen X F, Zhou A, Huang Q. An analysis of spleen aminopeptide oral lyophilized powder in the treatment of children after tonsillectomy[J]. Journal of Clinical Otorhinolaryngology, Head, and Neck Surgery, 2017, 31(21):1690-1692.
[7] 张寒放,倪锦玉,何改丽,等.应用"五脏同调"法论治儿童反复呼吸道感染[J].中医学报, 2020, 35(3):543-546.
[8] 王开梅,林志雄,胡祥英,等.金屏汤加减治疗小儿反复呼吸道感染的疗效及对免疫能力的调节作用[J].中华医院感染学杂志, 2020, 30(23):3602-3606.
[9] 陈四红,李晓屏,王小菊.健脾补肺膏治疗小儿肺脾两虚证慢性咳嗽的临床观察[J].中医药导报, 2018, 24(15):75-77.
[10] 田青,李景攀.补肺健脾汤联合噻托溴铵治疗慢性阻塞性肺疾病的效果及对患者FVC、FEV1、FEV1/FVC的影响[J].四川中医, 2019, 37(4):87-91.
[11] 中国医师协会儿科医师分会儿童耳鼻咽喉专业委员会.儿童反复上呼吸道感染临床诊治管理专家共识[J].中国实用儿科杂志, 2017, 32(10):721-725.
[12] 郝爱真,陈利平,高丽萍,等.小儿反复呼吸道感染的中医论治[J].中华医院感染学杂志, 2006, 16(1):49-50.
[13] 郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科学技术出版社, 2002:327-330.
[14] Li K L, Wang B Z, Li Z P, et al. Alterations of intestinal flora and the effects of probiotics in children with recurrent respiratory tract infection[J]. World Journal of Pediatrics, 2019, 15(3):255-261.
[15] Tarantino V, Savaia V, D'Agostino R, et al. Bacteriotherapy in children with recurrent upper respiratory tract infections[J]. European Review for Medical and Pharmacological Science, 2019, 23(Suppl 1):39-43.
[16] 陈峰,傅晓燕.儿童反复呼吸道感染易感因素和免疫调节防治研究进展[J].世界临床药物, 2020, 41(6):485-490.
[17] 石林波,杨燕,王丽华.补肺健脾法治疗重症肺部感染探析[J].中华中医药杂志, 2020, 35(1):192-194.
[18] 张高,杨柳柳,晏显妮,等.培土生金膏在慢性阻塞性肺疾病稳定期应用探析[J].江苏中医药, 2021, 53(6):72-74.
[19] 杨永菊,闵冬雨,张江,等.芍药甘草汤镇痛抗炎实验研究[J].辽宁中医药大学学报, 2018, 20(4):42-44.
[20] Brandt D, Hedrich C M. TCRαβ+CD3+CD4-CD8-(double negative) T cells in autoimmunity[J]. Autoimmunity Reviews, 2018, 17(4):422-430.
[21] Karakaya Y A, Atgan A, Ömer T G, et al. The relation of CD3, CD4, CD8 and PD-1 expression with tumor type and prognosis in epithelial ovarian cancers[J]. Ginekologia Polska, 2021, 92(5):344-351.